Journal
JOURNAL OF AUTOIMMUNITY
Volume 98, Issue -, Pages 33-43Publisher
ACADEMIC PRESS LTD- ELSEVIER SCIENCE LTD
DOI: 10.1016/j.jaut.2018.11.004
Keywords
Lupus nephritis; Nephrotoxic serum nephritis; Macrophages; RelA; NF-kappa B
Categories
Funding
- NIH
- National Institute of Arthritis and Musculoskeletal Diseases [3R01AR065594]
Ask authors/readers for more resources
Immune-mediated glomerulonephritis is a serious end organ pathology that commonly affects patients with systemic lupus erythematosus (SLE). A classic murine model used to study lupus nephritis (LN) is nephrotoxic serum nephritis (NTN), in which mice are passively transferred nephrotoxic antibodies. We have previously shown that macrophages are important in the pathogenesis of LN. To further investigate the mechanism by which macrophages contribute to the pathogenic process, and to determine if this contribution is mediated by NF-kappa B signaling, we created B6 mice which had ReIA knocked out in myeloid cells, thus inhibiting classical NF-kappa B signaling in this cell lineage. We induced NTN in this strain to assess the importance of macrophage derived NF-kappa B signaling in contributing to disease progression. Myeloid cell RelA knock out (KO) mice injected with nephrotoxic serum had significantly attenuated proteinuria, lower BUN levels, and improved renal histopathology compared to control injected wildtype B6 mice (WT). Inhibiting myeloid NF-kappa B signaling also decreased inflammatory modulators within the kidneys. We found significant decreases of IL-la, IFNg, and IL-6 in kidneys from KO mice, but higher IL-10 expression. Flow cytometry revealed decreased numbers of kidney infiltrating classically activated macrophages in KO mice as well. Our results indicate that macrophage NF-kappa B signaling is instrumental in the contribution of this cell type to the pathogenesis of NTN. While approaches which decrease macrophage numbers can be effective in immune mediated nephritis, more targeted treatments directed at modulating macrophage signaling and/or function could be beneficial, at least in the early stages of disease.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available